We found a tendency (not significant) of lower expression of the proliferation marker Ki67 in tumor tissues from mice treated with Th101 and mAbα10 by 84% and 51%, respectively, compared to mice treated with the control antibodies (Figure 7A,B). The gene discussed is MKI67; the disease is neoplasm.